Seaport Therapeutics price target maintained at $50.00 by HC Wainwright
HC Wainwright & Co maintained its $50.00-per-share price target for Seaport Therapeutics, according to Benzinga’s ratings actions cited via TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.